Skip to main content

Advertisement

SpringerLink
Log in

Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

The pathogenesis of proliferative diabetic retinopathy (PDR) remains poorly understood. Recent studies have implicated that monocyte chemoattractant protein-1 (MCP-1) is associated with diabetic microvascular or macrovascular complications. However, the relationship between single nucleotide polymorphism(SNP)c.2518A/G -rs1024611 in the MCP-1 gene with diabetic retinopathy remains controversial. In the present study, we evaluated the association of SNP in the MCP-1 gene with diabetic retinopathy (DR) and diabetic macular edema (DME) in a Chinese population from Northern China with type 2 diabetes.

Methods

We conducted a case–control study, which enrolled 1,043 subjects with type 2 diabetes (528 with DR, including 277PDR; 515 without DR), and SNP genotyping of c.2518A/G in the MCP-1 gene was performed using the polymerase chain reaction. Genomic DNA was isolated from 3 ml samples of whole blood using a modified conventional DNA extraction method. The genotype and allele frequencies of 2518A/G were studied by using an automated DNA sequencer (ABI PRISM 3730 DNA Sequencer).

Results

The demographic and clinical characteristics did not differ among genotype subgroups. The MCP-1(−2518) GG genotype was significantly associated with DR susceptibility with OR of 1.481 (95 % CI, 1.019-2.153) (P = 0.046). There were no significant differences in the MCP-1(−2518) G allele frequencies in DR compared to non-diabetic retinopathy (DNR) (P > 0.05, OR = 0.841, 95 % CI, 0.705–1.002). The MCP-1(−2518) GG genotype was significantly associated with high-risk PDR susceptibility with OR of 2.656 (95 % CI, 1.222–5.775) (P = 0.014). The MCP-1(−2518) G allele was significantly increased in high-risk PDR patients (P = 0.020, OR = 1.481, 95 % CI, 1.070–2.051) compared with A allele. Genotype and allele frequencies of various DME of the DR patients were compared, but there were no significant associations established (P > 0.05).

Conclusions

It is likely that the MCP-1 c.2518G/G genotype is a susceptibility gene for DR in Chinese type 2 diabetic patients, especially the high-risk PDR. There is no association with DME and c.2518G/G .

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Congdon NG, Friedman DS, Lietman T (2003) Important causes of visual impairment in the world today. JAMA 290:2057–2060

    Article  CAS  PubMed  Google Scholar 

  2. Lightman S, Towler HM (2003) Diabetic retinopathy. Clin Cornerstone 5:12–21

    Article  PubMed  Google Scholar 

  3. Paine SK, Basu A, Mondal LK, Sen A, Choudhuri S, Chowdhury IH, Saha A, Bhadhuri G, Mukherjee A, Bhattacharya B (2012) Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes. Mol Vis 18:2749–2757

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Mukaida N, Harada A, Matsushima K (1998) Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 9:9–23

    Article  CAS  PubMed  Google Scholar 

  5. Bian ZM, Elner VM, Yoshida A, Kunkel SL, Elner SG (2001) Elner, Signaling pathways for glycated human serum albumininduced IL-8 and MCP-1 secretion in human RPE cells. Invest Ophthalmol Vis Sci 42:1660–1668

    CAS  PubMed  Google Scholar 

  6. Abu el-Asrar AM, Van Damme J, Put W, Veckeneer M, Dralands L, Billiau A, Missotten L (1997) Monocyte chemotactic protein-1 in proliferative vitretinal disorders. Am J Ophthalmol 123:599–606

    Article  CAS  PubMed  Google Scholar 

  7. Capeans C, De Rojas MV, Lojo S, Salorio MS (1998) C–C chemokines in the vitreous of patients with proliferative vitretinopathy and proliferative diabetic retinopathy. Retina 18:546–550

    CAS  PubMed  Google Scholar 

  8. Tashimo A, Mitamura Y, Nagai S, Nakamura Y, Ohtsuka K, Mizue Y, Nishihira J (2004) Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy. Diabet Med 1292–1297

  9. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344–348

    Article  CAS  PubMed  Google Scholar 

  10. Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, Boehm BO, März W, Vassalli G (2004) Association between the A-2518G polymorphism in themonocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47:1574–1580

    Article  CAS  PubMed  Google Scholar 

  11. Yang B, Houlberg K, Millward A, Demaine A (2004) Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications. Cytokine 26:114–121

    Article  CAS  PubMed  Google Scholar 

  12. Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, Horváth L, Császár A (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1–2518 G/G genotype in CAD patients. Atherosclerosis 158:233–239

    Article  CAS  PubMed  Google Scholar 

  13. Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Imamura K, Ishibashi F, Kanda T, Kawai K, Osonoi T, Kashiwagi A, Kawamori R, Shimomura I, Yamasaki Y (2010) Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 89:9–12

    Article  Google Scholar 

  14. Jeon HJ, Choi HJ, Park BH, Lee YH, Oh T (2013) Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes. Yonsei Med J 54:621–625

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682

    Article  CAS  PubMed  Google Scholar 

  16. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M, Darius H, Lindemann S (2005) Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 69:1484–1489

    Article  CAS  PubMed  Google Scholar 

  17. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Franzoni F, Galetta F, Zignego AL, Ferrannini E (2009) CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. Dig Liver Dis 41:42–48

    Article  CAS  PubMed  Google Scholar 

  18. Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, Riente L, Ferrannini E (2009) High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol 27:22–27

    CAS  PubMed  Google Scholar 

  19. Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, Riente L, Ferrannini E (2008) High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. Autoimmunity 41:537–542

    Article  CAS  PubMed  Google Scholar 

  20. Antonelli A, Ferri C, Fallahi P, Colaci M, Giuggioli D, Ferrari SM, Frascerra S, Franzoni F, Galetta F, Ferrannini E (2008) Th1 and Th2 chemokine serum levels insystemic sclerosis in the presence or absence of autoimmune thyroiditis. J Rheumatol 35:1809–1811

    CAS  PubMed  Google Scholar 

  21. Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R (2006) Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes 30:1347–1355

    Article  CAS  Google Scholar 

  22. Salcedo R, Oppenheim JJ (2003) Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 10:359–370

    Article  CAS  PubMed  Google Scholar 

  23. Agostini C, Gurrieri C (2006) Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3:357–363

    Article  CAS  PubMed  Google Scholar 

  24. Evans OVH, La SX, Fisher IB, Rajkumar V, Abraham DJ, Black CM, Denton CP (2003) Monocyte chemoattractant protein 3 as a mediator of fibrosis: overexpression in systemic sclerosis and the type 1 tight –skin mouse. Arthritis Rheum 48:1979–1991

    Article  PubMed  Google Scholar 

  25. Niu J, Kolattukudy PE (2009) Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci 117:95–109

    Article  CAS  PubMed  Google Scholar 

  26. Kolattukudy PE, Niu J (2012) Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res 110:174–189

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313–326

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Hong KH, Ryu J, Han KH (2005) Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105:1405–1407

    Article  CAS  PubMed  Google Scholar 

  29. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96:34–40

    CAS  PubMed  Google Scholar 

  30. Miller JW, Adamis AP, Aiello LP (1997) Vascular endothelial growth factor inocular neovascularization and proliferative retinopathy. Diabetes Metab Rev 13:37–50

    Article  CAS  PubMed  Google Scholar 

  31. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344–348

    Article  CAS  PubMed  Google Scholar 

  32. Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, Tiriticco M, Mariani C, Forloni G, Pettenati C, Baron P, Conti G, Bresolin N, Scarpini E (2004) MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25:1169–1173

    Article  CAS  PubMed  Google Scholar 

  33. Palmer ND, Langefeld CD, Ziegler JT, Hsu F, Haffner SM, Fingerlin T, Norris JM, Chen YI, Rich SS, Haritunians T, Taylor KD, Bergman RN, Rotter JI, Bowden DW (2010) Candidate loci for insulin sensitivity and disposition index from a genome Wide Association Analysis of Hispanics in the IRAS family study. Diabetologia 53(2):281–289

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. No authors listed (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98:766–785

  35. Gardner TW, Antonetti DA (2008) Novel potential mechanisms for diabetic macular edema:leveraging new investigational approaches. Curr Diabet Rep 8:263–269

    Article  CAS  Google Scholar 

Download references

Acknowledgments

Li Dong, Xiao Ying lv, Bin Jie Wang carried out the experiment, data analysis and manuscript preparation. Ye Qing Wang, Hua Mu, Zhuo Lei Feng and Ping Liu were involved in the experimental design, sample collection, and grant and ethics applications. This work was supported by a grant from Heilongjiang Provincial Department of Education Science and Technology Research. (12531414)

Competing interests

None.

Patient consent

Obtained.

Ethics approval was obtained from the institute ethics committee, Harbin Medical University

Provenance and peer review

Not commissioned; externally peer reviewed

Author information

Authors and Affiliations

  1. Key Laboratory of Harbin Medical University Eye Center, Eye Hospital, First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, 150001, Heilongjiang Province, People’s Republic of China

    Li Dong, Xiao Ying lv, Bin Jie Wang, Ye Qing Wang, Hua Mu, Zhuo Lei Feng & Ping Liu

Authors
  1. Li Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao Ying lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin Jie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ye Qing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hua Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhuo Lei Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ping Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, L., lv, X.Y., Wang, B.J. et al. Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes. Graefes Arch Clin Exp Ophthalmol 252, 1921–1926 (2014). https://doi.org/10.1007/s00417-014-2651-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2651-1

Keywords

Search

Navigation